Hot Pursuit     05-Aug-21
Alembic Pharma receives final approval for OCD treatment drug
Alembic Pharmaceuticals on Thursday announced that it has received final approval from the USFDA for its Abbreviated New Drug Application (ANDA) for Clomipramine Hydrochloride Capsules.
The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Anafranil Capsules of SpecGX LLC. Clomipramine Hydrochloride Capsules are indicated for the treatment of obsessions and compulsions in patients with Obsessive-Compulsive Disorder (OCD).

According to IQVIA, Clomipramine Hydrochloride Capsules USP have an estimated market size of $32 million for twelve months ending June 2021. Alembic has a cumulative total of 149 ANDA approvals from USFDA.

Shares of Alembic Pharma were trading 1.07% lower at Rs 778 on BSE.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world.

Previous News
  Alembic Pharma spurts on USFDA nod for leukemia drug
 ( Hot Pursuit - 01-Jul-24   11:06 )
  Alembic Pharmaceuticals resumes operations at Namthang unit
 ( Corporate News - 01-Feb-24   20:15 )
  Volumes soar at Aditya Birla Fashion & Retail Ltd counter
 ( Hot Pursuit - 08-May-23   14:30 )
  Alembic Pharmaceuticals receives USFDA tentative approval for Bosutinib tablets
 ( Corporate News - 01-Jul-24   10:44 )
  Alembic Pharma's Panelav facility gets EIR from USFDA
 ( Hot Pursuit - 09-Dec-22   14:23 )
  Alembic Pharmaceuticals consolidated net profit declines 85.86% in the March 2022 quarter
 ( Results - Announcements 02-May-22   16:33 )
  USFDA issues EIR for Alembic's Panelav oncology injectable formulation unit
 ( Corporate News - 09-Dec-22   13:39 )
  Alembic Pharmaceuticals consolidated net profit declines 29.03% in the December 2022 quarter
 ( Results - Announcements 01-Feb-23   17:10 )
  Alembic Pharmaceuticals gets USFDA approval
 ( Corporate News - 27-Oct-22   11:52 )
  Alembic Pharma rises on USFDA nod for breast cancer drug
 ( Hot Pursuit - 01-Apr-24   13:52 )
  Alembic Pharma reports turnaround Q1 numbers
 ( Hot Pursuit - 05-Aug-23   12:56 )
Other Stories
  Tata Motors JLR wholesale rises 5% YoY in Q1
  06-Jul-24   13:01
  Marico's domestic biz sees modest volume growth in Q1
  06-Jul-24   12:25
  Titan revenue rises 9% YoY, adds 61 stores in Q1
  06-Jul-24   11:09
  Dabur India expects mid to high digit revenue growth in Q1
  06-Jul-24   10:40
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
Back Top